Expanding the phenotypic spectrum of TRAPPC11-related muscular dystrophy : 25 Roma individuals carrying a founder variant
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..
BACKGROUND: Limb-girdle muscular dystrophies (LGMD) are a heterogeneous group of genetically determined muscle disorders. TRAPPC11-related LGMD is an autosomal-recessive condition characterised by muscle weakness and intellectual disability.
METHODS: A clinical and histopathological characterisation of 25 Roma individuals with LGMD R18 caused by the homozygous TRAPPC11 c.1287+5G>A variant is reported. Functional effects of the variant on mitochondrial function were investigated.
RESULTS: The c.1287+5G>A variant leads to a phenotype characterised by early onset muscle weakness, movement disorder, intellectual disability and elevated serum creatine kinase, which is similar to other series. As novel clinical findings, we found that microcephaly is almost universal and that infections in the first years of life seem to act as triggers for a psychomotor regression and onset of seizures in several individuals with TRAPPC11 variants, who showed pseudometabolic crises triggered by infections. Our functional studies expanded the role of TRAPPC11 deficiency in mitochondrial function, as a decreased mitochondrial ATP production capacity and alterations in the mitochondrial network architecture were detected.
CONCLUSION: We provide a comprehensive phenotypic characterisation of the pathogenic variant TRAPPC11 c.1287+5G>A, which is founder in the Roma population. Our observations indicate that some typical features of golgipathies, such as microcephaly and clinical decompensation associated with infections, are prevalent in individuals with LGMD R18.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
|---|---|
| Enthalten in: |
Journal of medical genetics - 60(2023), 10 vom: 17. Okt., Seite 965-973 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Epilepsy |
|---|
| Anmerkungen: |
Date Completed 25.09.2023 Date Revised 19.10.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1136/jmg-2022-109132 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM35700356X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM35700356X | ||
| 003 | DE-627 | ||
| 005 | 20231226071643.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/jmg-2022-109132 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1189.xml |
| 035 | |a (DE-627)NLM35700356X | ||
| 035 | |a (NLM)37197784 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Justel, Maria |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Expanding the phenotypic spectrum of TRAPPC11-related muscular dystrophy |b 25 Roma individuals carrying a founder variant |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.09.2023 | ||
| 500 | |a Date Revised 19.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. | ||
| 520 | |a BACKGROUND: Limb-girdle muscular dystrophies (LGMD) are a heterogeneous group of genetically determined muscle disorders. TRAPPC11-related LGMD is an autosomal-recessive condition characterised by muscle weakness and intellectual disability | ||
| 520 | |a METHODS: A clinical and histopathological characterisation of 25 Roma individuals with LGMD R18 caused by the homozygous TRAPPC11 c.1287+5G>A variant is reported. Functional effects of the variant on mitochondrial function were investigated | ||
| 520 | |a RESULTS: The c.1287+5G>A variant leads to a phenotype characterised by early onset muscle weakness, movement disorder, intellectual disability and elevated serum creatine kinase, which is similar to other series. As novel clinical findings, we found that microcephaly is almost universal and that infections in the first years of life seem to act as triggers for a psychomotor regression and onset of seizures in several individuals with TRAPPC11 variants, who showed pseudometabolic crises triggered by infections. Our functional studies expanded the role of TRAPPC11 deficiency in mitochondrial function, as a decreased mitochondrial ATP production capacity and alterations in the mitochondrial network architecture were detected | ||
| 520 | |a CONCLUSION: We provide a comprehensive phenotypic characterisation of the pathogenic variant TRAPPC11 c.1287+5G>A, which is founder in the Roma population. Our observations indicate that some typical features of golgipathies, such as microcephaly and clinical decompensation associated with infections, are prevalent in individuals with LGMD R18 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a epilepsy | |
| 650 | 4 | |a genetics, population | |
| 650 | 4 | |a movement disorders | |
| 650 | 4 | |a neuromuscular diseases | |
| 650 | 7 | |a TRAPPC11 protein, human |2 NLM | |
| 650 | 7 | |a Vesicular Transport Proteins |2 NLM | |
| 700 | 1 | |a Jou, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Sariego-Jamardo, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Juliá-Palacios, Natalia Alexandra |e verfasserin |4 aut | |
| 700 | 1 | |a Ortez, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Poch, Maria Luisa |e verfasserin |4 aut | |
| 700 | 1 | |a Hedrera-Fernandez, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Gomez-Martin, Hilario |e verfasserin |4 aut | |
| 700 | 1 | |a Codina, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Dominguez-Carral, Jana |e verfasserin |4 aut | |
| 700 | 1 | |a Muxart, Jordi |e verfasserin |4 aut | |
| 700 | 1 | |a Hernández-Laín, Aurelio |e verfasserin |4 aut | |
| 700 | 1 | |a Vila-Bedmar, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Zulaica, Miren |e verfasserin |4 aut | |
| 700 | 1 | |a Cancho-Candela, Ramon |e verfasserin |4 aut | |
| 700 | 1 | |a Castro, Margarita Del Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a de la Osa-Langreo, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Peña-Valenceja, Alfonso |e verfasserin |4 aut | |
| 700 | 1 | |a Marcos-Vadillo, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Prieto-Matos, Pablo |e verfasserin |4 aut | |
| 700 | 1 | |a Pascual-Pascual, Samuel Ignacio |e verfasserin |4 aut | |
| 700 | 1 | |a López de Munain, Adolfo |e verfasserin |4 aut | |
| 700 | 1 | |a Camacho, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Estevez-Arias, Berta |e verfasserin |4 aut | |
| 700 | 1 | |a Musokhranova, Uliana |e verfasserin |4 aut | |
| 700 | 1 | |a Olivella, Mireia |e verfasserin |4 aut | |
| 700 | 1 | |a Oyarzábal, Alfonso |e verfasserin |4 aut | |
| 700 | 1 | |a Jimenez-Mallebrera, Cecilia |e verfasserin |4 aut | |
| 700 | 1 | |a Domínguez-González, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Nascimento, Andrés |e verfasserin |4 aut | |
| 700 | 1 | |a García-Cazorla, Àngels |e verfasserin |4 aut | |
| 700 | 1 | |a Natera-de Benito, Daniel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medical genetics |d 1964 |g 60(2023), 10 vom: 17. Okt., Seite 965-973 |w (DE-627)NLM000228656 |x 1468-6244 |7 nnns |
| 773 | 1 | 8 | |g volume:60 |g year:2023 |g number:10 |g day:17 |g month:10 |g pages:965-973 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/jmg-2022-109132 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 60 |j 2023 |e 10 |b 17 |c 10 |h 965-973 | ||